01 4Onpattro
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2020 Revenue in Millions : 306
2019 Revenue in Millions : 166
Growth (%) : 84
Main Therapeutic Indication : Genetic Disorders
Currency : USD
2021 Revenue in Millions : 475
2020 Revenue in Millions : 306
Growth (%) : 55
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2022 Revenue in Millions : 558
2021 Revenue in Millions : 475
Growth (%) : 17
Main Therapeutic Indication : Genetic Diseases
Currency : USD
2023 Revenue in Millions : 355
2022 Revenue in Millions : 558
Growth (%) : -36
LOOKING FOR A SUPPLIER?
